DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jun 28, 2017
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Purchase
Common Stock
2017-06-26$3.60/sh+6,700$24,120→ 53,345 total
Footnotes (1)
- [F1]The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $32,160. Reported price is based on exchange rate of 0.75.